Abstract:Transgene expression after the administration of recombinant adenovirus with E1 deleted is constantly transient. It is admitted that E1A-substituting activities of cellular or viral origin allow viral antigen synthesis and trigger cytotoxic lymphocyte-mediated clearance of the recipient cells. Our approach to solving this problem relies on the additional deletion of the E4 region from the vector backbone as this region upregulates viral gene expression at both transcriptional and posttranscriptional levels. As a prerequisite to the construction of E1 E4 doubly defective adenoviruses, we investigated the possibility of transcomplementing both functions within a single cell. In particular, the distal ORF6+ORF7 segment from the E4 locus of adenovirus type 5 was cloned under the control of the dexamethasone-inducible mouse mammary tumor virus long terminal repeat. Following transfection into 293 cells, clone IGRP2 was retained and characterized as it can rescue the growth defect of all E1+ E4- adenoviral deletants tested. DNA and RNA analysis experiments verified that the mouse mammary tumor virus promoter drives the expression of the ORF6+ORF7 unit and permits its bona fide alternative splicing, generating ORF6/7 mRNA in addition to the ORF6-expressing primary transcript. Importantly, IGRP2 cells sustain cell confluence for a period longer than that of 293 parental cells and allow the plaque purification of E1- or E4- defective viruses. The dual expression of E1 and E4 regulatory genes within IGRP2 cells is demonstrated by the construction, plaque purification, and helper-free propagation of recombinant lacZ-encoding doubly defective adenoviruses harboring different E4 deletions. In addition, the emergence, if any, of replicative particles during viral propagation in this novel packaging cell line will be drastically impaired as only a limited segment of E4 has been integrated.

Construction and identification of recombinant replication-defective adenoviruses harbouring expression cassettes of I540-PTD and I540-PTD4

An improved HAdV-41 E1B55K-expressing 293 cell line for packaging fastidious adenovirus.

Enhanced Growth of Recombinant Human Adenovirus Type 41 (Hadv-41) Carrying ADP Gene

Constructing Prokaryotic Vector of BC047440 Gene Expression and Purification of Its Recombinant Protein

[Construction and Identification of Recombinant Adenoviral Vector Encoding B7-H4 Gene].

Construction of Cell Line Stably Expressing IBDV VP2 Protein Mutants

Construction of an eukaryotic expression vector containing IBDV VP2/4/3 and ChIL-2 fusion gene and their expression in Vero cells

[Construction and Identification of Recombinant Adenovirus Expressing Rat Proteoglycan II].

Establishment of Six Adenoviruses That Express the Full Length of Connective Tissue Growth Factor and Its Deletion Mutants

Construction, Packaging and Titration of Recombinant Adeno-Associated Virus Vectors Contaning Antitumor Genes

[Construction and identification of a novel adeno-integrase hybrid system for hemophilia B]

Construction and identification of recombinant adenovirus carrying IGF2 imprinting system

Rapid Construction of an Infectious Clone of Fowl Adenovirus Serotype 4 Isolate

Construction of Recombinant Adenoviras Expressing RSV F Gene

The Construction and Characterization of a Novel Adenovirus Vector of Artificial Microrna Targeting EGFR.

Construction of Replication-Deficient Recombinant Adenovirus Vector with Htfpi-2 Gene by Admax System and Expression in U937 Monocytes in Vitro

Construction of Htert and Cox-2 Dependent Oncolytic Adenovirus

Preparation and Identification of Recombinant Adenovirus Carrying Human Inhibitors of Differentiation 3

Construction and identification of recombinant adenovirus vector expressing human S100A8

Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit

[Construction and Verification of a Novel Triple-Regulated Oncolytic Adenovirus Carrying Gene Pdcd5].